Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6SK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,548
Award facts
- Contract value 100% obligated
- $39,548.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,548.43 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a non-set-aside, competitively awarded contract with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with the DLA Troop Support Medical, a $999.9 billion prime vendor agreement designated SPE2DX and running through December 2026, which provides comprehensive global pharmaceutical support to military healthcare programs worldwide.
Repatha is a PCSK9 inhibitor prescribed for the management of high cholesterol in patients with established cardiovascular disease or those at significant risk. AmerisourceBergen, operating under its parent company Cencora, Inc., serves as a critical pharmaceutical distributor supplying the federal government with an extensive range of brand-name and generic medications across multiple therapeutic domains. The company's role in this delivery order supports the Defense Health Agency and military treatment facilities' ongoing need for specialized cardiovascular and preventive care medications to serve active-duty personnel, military retirees, and their families.
Quick answers
Who was awarded contract SPE2DR26F6SK4?
SPE2DR26F6SK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6SK4 worth?
The government has obligated $39,548 on SPE2DR26F6SK4.
Is contract SPE2DR26F6SK4 an order under another contract?
Yes. SPE2DR26F6SK4 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SK4 competed?
The extent of competition for SPE2DR26F6SK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award